Drug Approval | May 09, 2022
Glenmark receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA